{"title":"Inflammation-Activatable Nanoscavengers for Sustainable Cell-Free DNA Capture and Cleavage.","authors":"Mengyuan Yin,Chenglong Ge,Yang Zhou,Renxiang Zhou,Yiyao Yang,Yu Qian,Jianyin He,Jingrui Shen,Lichen Yin","doi":"10.1002/adma.202504557","DOIUrl":null,"url":null,"abstract":"Cell-free DNA (cfDNA) scavenging using cationic materials represents a promising therapeutic modality for autoimmune diseases (AIDs) such as inflammatory bowel disease (IBD). This approach, however, suffers from critical issues of binding saturation for cfDNA and risk of re-exposure of the captured cfDNA. Herein, an inflammation-activatable nanoscavenger integrating both cfDNA capture and cleavage functions is constructed from dendrimer-templated, charge- and conformation-transformable polypeptides with Cyclen-Zn complexes conjugated on the backbone termini. At neutral pH, the polypeptides containing both cis-aconitic acid and guanidine side chains adopt negative charges and random-coiled conformation, thus featuring long blood circulation and high accumulation to the inflamed intestinal tissue. Inside the mildly acidic inflammatory microenvironment, the polypeptides transform to the positively charged α-helices due to removal of the cis-aconitic acid groups, thus enabling robust cfDNA capture through electrostatic attraction, salt bridging, and spatial confinement within the cavity between adjacent rod-like helices. Subsequently, the exposed Cyclen-Zn endows the nanoscavenger with DNase-like activity to cleave the captured cfDNA, allowing sustainable cfDNA capture and scavenging. In consequence, the nanoscavenger efficiently inhibits TLR9 activation and restores immune homeostasis in IBD mice. This study proposes an enlightened strategy for sustainable cfDNA scavenging, and it renders a promising modality for AIDs treatment.","PeriodicalId":114,"journal":{"name":"Advanced Materials","volume":"9 1","pages":"e2504557"},"PeriodicalIF":27.4000,"publicationDate":"2025-06-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Materials","FirstCategoryId":"88","ListUrlMain":"https://doi.org/10.1002/adma.202504557","RegionNum":1,"RegionCategory":"材料科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Cell-free DNA (cfDNA) scavenging using cationic materials represents a promising therapeutic modality for autoimmune diseases (AIDs) such as inflammatory bowel disease (IBD). This approach, however, suffers from critical issues of binding saturation for cfDNA and risk of re-exposure of the captured cfDNA. Herein, an inflammation-activatable nanoscavenger integrating both cfDNA capture and cleavage functions is constructed from dendrimer-templated, charge- and conformation-transformable polypeptides with Cyclen-Zn complexes conjugated on the backbone termini. At neutral pH, the polypeptides containing both cis-aconitic acid and guanidine side chains adopt negative charges and random-coiled conformation, thus featuring long blood circulation and high accumulation to the inflamed intestinal tissue. Inside the mildly acidic inflammatory microenvironment, the polypeptides transform to the positively charged α-helices due to removal of the cis-aconitic acid groups, thus enabling robust cfDNA capture through electrostatic attraction, salt bridging, and spatial confinement within the cavity between adjacent rod-like helices. Subsequently, the exposed Cyclen-Zn endows the nanoscavenger with DNase-like activity to cleave the captured cfDNA, allowing sustainable cfDNA capture and scavenging. In consequence, the nanoscavenger efficiently inhibits TLR9 activation and restores immune homeostasis in IBD mice. This study proposes an enlightened strategy for sustainable cfDNA scavenging, and it renders a promising modality for AIDs treatment.
期刊介绍:
Advanced Materials, one of the world's most prestigious journals and the foundation of the Advanced portfolio, is the home of choice for best-in-class materials science for more than 30 years. Following this fast-growing and interdisciplinary field, we are considering and publishing the most important discoveries on any and all materials from materials scientists, chemists, physicists, engineers as well as health and life scientists and bringing you the latest results and trends in modern materials-related research every week.